DULUTH, Ga.--(BUSINESS WIRE)--Sept. 5, 2006--Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has been retained by IDEV Technologies, Inc. to exclusively broker the sale of its FDA cleared and CE Marked product lines, the Texan® LONGhorn and mini-Tex(TM) foreign body retrieval devices and the AKonya Eliminator(TM) and AKonya Eliminator Plus(TM) mechanical thrombectomy devices.
Paul Gianneschi, Managing Principal at Hatch Medical commented, “We are excited to be partnering with IDEV Technologies on this assignment and look forward to successfully brokering the acquisition or license of IDEV’s unique technologies; no doubt complimentary to any endovascular product line.”
Thomas Tully, IDEV’s Chairman and Chief Executive Officer added, “We are very pleased to have the expertise of Hatch Medical on our side as we work through the divestiture of these product lines. Divesting these businesses allows our team to focus on our emerging stent business, which we believe has unmatched potential.”
IDEV Technologies, Inc. is an innovator and emerging leader in peripheral stent technologies. IDEV is based in Houston, Texas and its current portfolio contains over thirty technologies exclusively licensed from the M.D. Anderson Cancer Center, representing over a $5.0 billion dollar market opportunity worldwide.
For additional information on this, or other Hatch Medical, L.L.C. products and services, e-mail the company at info@hatchmedical.com, or call 770-476-9940. This release and additional news about Hatch Medical can be obtained by visiting the company’s web site at: http://www.hatchmedical.com.
Contact: Hatch Medical, L.L.C. Paul Gianneschi, 770-476-9940 or Steve Hvozda, 404-892-0405 www.hatchmedical.com
Source: Hatch Medical, L.L.C.
